1610614: LINEZOLID INJECTION.
The LINEZOLID INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS INFUSION, features_provided: STERILE, primary_container_type: BAG, total_primary_container_quantity: 10, primary_container_content_quantity: 300.0 MILLILITERS, part_name_assigned_by_controlling_agency: LINEZOLID INJECTION, 600MG PER 300ML, 10S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-697-9560, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS INFUSION |
| features_provided | STERILE |
| primary_container_type | BAG |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 300.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | LINEZOLID INJECTION, 600MG PER 300ML, 10S |
| NSN | 6505-01-697-9560 |
| ADMINISTRATION | INTRAVENOUS INFUSION |
| PRIMARY CONTAINER CONTENT QUANTITY | 300.0 MILLILITERS |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | BAG |
| SPECIAL FEATURES | INDICATED FOR THE TREATMENT OF NOSOCOMIAL PNEUMONIA CAUSED BY STAPHYLOCOCCUS AUREUS (METHICILLIN-SUSCEPTIBLE AND RESISTANT ISOLATES) OR STREPTOCOCCUS CCUS AUREUS PNEUMONIAE; STORE AT 20C TO 25C (68F TO 77F) (SEE USP CONTROLLED ROOM TEMPERATURE); PROTECT FROM LIGHT; RECOMMENDED THAT THE INFUSION BAGS BEKEPT IN THE OVERWRAP UNTIL READY TO USE; DO NOT FREEZE; THE CONTAINER CLOSURE IS NOT MADE WITH NATURAL RUBBER LATEX; NON-PVC, NON-DEHP, STERILE; FOR INTRAVENOUS INFUSION; SINGLE USE ONLY; DISCARD UNSUSED PORTION; PACKAGE OF 10 BAGS; EACH BAG CONTAINS 300ML. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LINEZOLID INJECTION, 600MG PER 300ML, 10S |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |